International Genetics and Genomics of Diseases

 Non-Homologous End Joining (NHEJ) Non-Homologous End Joining (NHEJ) is a major DNA repair pathway responsible for repairing double-strand breaks (DSBs) in DNA. Unlike homologous recombination, NHEJ does not require a homologous DNA template. Instead, it directly joins the broken DNA ends together through a series of enzymatic steps involving end recognition, processing, and ligation. Key proteins involved in this pathway include the Ku70/Ku80 complex , DNA-PKcs , Artemis , and DNA ligase IV . NHEJ is active throughout the cell cycle and is particularly important in rapidly dividing cells . While it efficiently restores DNA integrity , it is considered an error-prone mechanism because small insertions or deletions may occur at the repair site. NHEJ also plays an essential role in immune system development through V(D)J recombination . Non-Homologous End Joining (NHEJ) DNA Double-Strand Break Repair DNA Damage Response Ku70/Ku80 Complex DNA-PKcs DNA Ligase IV Artemis Protein Genom...

 DNA Repair Mechanisms Diagram A DNA Repair Mechanisms Diagram visually illustrates the cellular pathways that detect and repair damage in DNA to maintain genome stability and prevent mutations. Cells are constantly exposed to DNA damage from environmental factors such as radiation, chemicals, and oxidative stress, as well as normal cellular processes like DNA replication . The diagram typically highlights the major repair pathways, including base excision repair (BER) for small base lesions, nucleotide excision repair (NER) for bulky DNA damage, mismatch repair (MMR) for replication errors, and double-strand break repair mechanisms such as homologous recombination (HR) and non-homologous end joining (NHEJ) . These pathways work together to preserve genetic integrity, reduce mutation rates, and prevent diseases such as cancer. DNA Repair Mechanisms DNA Damage Repair Base Excision Repair (BER) Nucleotide Excision Repair (NER) Mismatch Repair (MMR) Homologous Recombination (...

Microsatellite Instability Testing Genomic instability in cancer cells refers to the increased frequency of genetic alterations that occur during tumor development and progression. Unlike normal cells, cancer cells accumulate mutations, chromosomal rearrangements, copy number alterations, and aneuploidy at a significantly higher rate. This instability arises from defects in DNA repair pathways, replication stress, telomere dysfunction, and impaired cell cycle checkpoints. Genomic instability is a key driver of tumor heterogeneity, enabling cancer cells to adapt, evolve, and develop resistance to therapy. It contributes to the activation of oncogenes, inactivation of tumor suppressor genes, and the emergence of aggressive cancer phenotypes. Clinically, understanding genomic instability helps guide targeted therapies, immunotherapy decisions, and precision oncology strategies. Genomic Instability Cancer Cells Chromosomal Instability (CIN) Microsatellite Instability (MSI) DNA Damage D...

Single-Gene (Cystic Fibrosis) Cystic Fibrosis is a hereditary single-gene genetic disorder caused by mutations in the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) gene . It primarily affects the lungs, pancreas, and other organs that produce mucus and digestive fluids. In individuals with cystic fibrosis, the CFTR gene mutation disrupts the normal transport of chloride and sodium ions across cell membranes, leading to the production of thick, sticky mucus . This mucus can clog airways, cause chronic respiratory infections, impair digestion, and reduce nutrient absorption. Cystic fibrosis follows an autosomal recessive inheritance pattern , meaning a child must inherit two defective copies of the gene—one from each parent—to develop the disease. Advances in genetic screening , early diagnosis, and targeted therapies have significantly improved life expectancy and disease management. Single-Gene Disorder, Cystic Fibrosis, CFTR Gene, Autosomal Recessive Inheritance, Genet...

Marker Assisted Selection Marker-Assisted Selection (MAS) is a modern breeding technique that uses molecular markers linked to specific genes or quantitative trait loci (QTLs) to select individuals with desirable genetic traits. Instead of relying solely on visible characteristics (phenotypes), MAS enables breeders to identify and select plants or animals carrying beneficial genes at the DNA level. This approach increases the efficiency, accuracy, and speed of breeding programs, particularly for traits that are difficult to observe directly, such as disease resistance, stress tolerance, yield potential, or quality characteristics. MAS is widely applied in crop improvement , livestock breeding, and genetic research , helping accelerate the development of improved varieties with enhanced productivity, resilience, and adaptability to environmental challenges. Marker-Assisted Selection, Molecular Markers, Genetic Markers, QTL Mapping, Genomic Selection, DNA Markers, Crop Improvement, Bre...

Crop Improvement In Agriculture Crop Improvement in agriculture refers to the scientific process of enhancing the genetic potential and performance of crops to increase productivity, quality, and resilience. It involves the use of traditional breeding methods, modern biotechnology, and genomic tools to develop crop varieties with desirable traits such as higher yield, resistance to pests and diseases, tolerance to drought and salinity, and improved nutritional value. Techniques such as hybridization, selection, molecular breeding , and gene editing are widely used to accelerate crop development. Crop improvement plays a critical role in ensuring global food security, supporting sustainable agriculture, and helping crops adapt to climate change and environmental stresses. Crop Improvement Plant Breeding Agricultural Genetics Hybrid Crops Molecular Breeding Genomic Selection High-Yield Varieties Disease Resistance Drought Tolerance Sustainable Agriculture Agricultural Biotechnology Tr...